CNote Closes Series A Investment, Cementing the Women-Led Impact Platform's Leadership in Closing the US Wealth Gap Through Financial Innovation
September 19, 2022 09:00 ET | CNote
OAKLAND, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Building on the momentum of its impact platform—already adopted by corporate leaders including Apple, Mastercard, Netflix and PayPal as a scalable...
BB_Stacked_BW_TM_RGB.jpg
Beta Bionics Appoints Sean Saint as CEO and Board Member
August 15, 2022 16:00 ET | Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational devices limited by Federal (or United States) law to investigational use. Not available for sale. CONCORD, Mass., Aug. 15, 2022 ...
Ferrer Invests More Than 60% of Its Net Profits in Social and Environmental Causes
July 28, 2022 08:02 ET | Ferrer
BARCELONA, Spain, July 28, 2022 (GLOBE NEWSWIRE) -- In 2021 the pharmaceutical company Ferrer invested 61.4% of its net profits in social and environmental causes, as part of its purpose to make a...
BB_Stacked_BW_TM_RGB.jpg
The Insulin-Only Bionic Pancreas Pivotal Trial Showed Consistent Mean HbA1c Reductions Across a Variety of Subgroups at ADA’s 82nd Scientific Sessions
June 09, 2022 14:00 ET | Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The randomized Insulin-Only Bionic Pancreas...
CNote's Community Investment Platform Nears $300M, a Sign of Balance Sheet Activism Rising Across Business Sectors
June 02, 2022 09:00 ET | CNote Group, Inc.
OAKLAND, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Recent commitments from Apple, Netflix and Xylem have pushed the total funding being deployed to communities via CNote's investment platform to...
BB_Stacked_BW_TM_RGB.jpg
Pivotal Trial Results of the iLet® Bionic Pancreas to Be Presented at the ADA’s 82nd Scientific Sessions
June 01, 2022 05:00 ET | Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Roy W. Beck will moderate a session: The...
WeTransfer_Black.png
WeTransfer Launches Emerging Creative Hubs Index and $100,000 Grant Program
May 11, 2022 09:00 ET | WeTransfer
NEW YORK, May 11, 2022 (GLOBE NEWSWIRE) -- WeTransfer, a leading provider of creative productivity tools announced today the launch of its newest research, the Emerging Creative Hubs Index, and a...
BB_Stacked_BW_TM_RGB.jpg
Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer
May 10, 2022 05:00 ET | Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Gilad Glick, former Chief Executive Officer,...
CNote Expands Access to Capital for Community Financial Institutions With $25 Million From Apple to Support Communities of Color
May 05, 2022 08:00 ET | CNote Group, Inc.
OAKLAND, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Today, CNote, an Oakland-based fintech, announced that Apple will use the CNote platform to deploy $25 million into underserved communities across...
BB_Stacked_BW_TM_RGB.jpg
The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes
April 30, 2022 04:00 ET | Beta Bionics, Inc.
The trial achieved key primary and secondary endpoints, demonstrating improved outcomes over standard of care for people living with type 1 diabetes.The study population — 440 adults and children 6...